Exchange: NASDAQ·Updated 07:13 PM EDT
CTSO logo

CTSOCytosorbents Corp

$0.3936
$0.0135
(3.55%)
Today
Closed $0.3936
$0.0074
(1.88%)
After Hours
EarningsAug 6
Mkt Cap$23.89M
Vol39,384.00
News
all
press releases
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights PR Newswire PRINCETON, N.J., July 20, 2026 PRINCETON, N.J., July 20, 2026 /PRNewswire/ -- CytoSorbents...
PR Newswire
More News
Transcript: CytoSorbents Q1 2026 Earnings Conference Call
read more...
Benzinga
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and...
PR Newswire
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights PR Newswire...
PR Newswire
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business...
PR Newswire
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical...
PR Newswire
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent...
PR Newswire
What Analysts Are Saying About CytoSorbents Stock
read more...
Benzinga
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and...
PR Newswire
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.